Core Laboratories
CLB
274 hedge funds and large institutions have $2.23B invested in Core Laboratories in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 106 increasing their positions, 91 reducing their positions, and 58 closing their positions.
16% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 91
3.56% more ownership
Funds ownership: 105.06% → 108.62% (+3.6%)
9% less capital invested
Capital invested by funds: $2.43B → $2.23B (-$208M)
10% less funds holding
Funds holding: 304 → 274 (-30)
34% less call options, than puts
Call options by funds: $15.3M | Put options by funds: $23M
50% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
+$37.2M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
+$26.5M |
| 3 |
VanEck Associates
New York
|
+$26.5M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$22.4M |
| 5 |
MPI
Mairs & Power Inc
St Paul,
Minnesota
|
+$22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$49.8M |
| 2 |
ClearBridge Investments
New York
|
-$46.9M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$23.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$18.4M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$14.7M |
CLB Hedge Fund Activity: Q3 2019 in Review
274 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2019, worth a combined $2.23B — down 8.5% from $2.43B a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of CLB and 29 opened new positions — a net loss of 29 holders — while 91 trimmed existing stakes and 106 added.
The largest buyer was Sterling Capital Management, opening a new position worth an estimated $37.2M. The largest seller was Millennium Management, cutting an estimated $49.8M.
- 274 institutional investors held Core Laboratories (CLB) as of Q3 2019, down from 304 in Q2 2019.
- Funds reported $2.23B of Core Laboratories stock for Q3 2019, down 8.5% quarter-over-quarter.
- 29 funds opened new Core Laboratories positions in Q3 2019 and 58 closed out, a net change of -29 holders.
- The largest Core Laboratories buyer in Q3 2019 was Sterling Capital Management, an estimated $37.2M added.
- The largest Core Laboratories seller in Q3 2019 was Millennium Management, an estimated $49.8M sold.
Based on aggregated 13F filings for Q3 2019.